Korean pharmaceutical company GC Biopharma has announced it has applied for approval of its GC1109 recombinant anthrax vaccine to the Korean Ministry of Food and Drug Safety. According to GC Biophrama “GC1109 contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of proteins that comprise anthrax […]
The post is from MAD MAD NEWS